NCT07360496

Brief Summary

This study investigated the relationships between core endurance, finger grip strength, fatigue, and hand function in patients with rheumatoid arthritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
113

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 8, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2023

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2024

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

January 9, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 22, 2026

Completed
Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

9 months

First QC Date

January 9, 2026

Last Update Submit

January 16, 2026

Conditions

Keywords

Rheumatoid ArthritisCore EndurancePinchmeterGrip StrengthFatigue

Outcome Measures

Primary Outcomes (1)

  • Core endurance

    Modified prone plank. This test began with a crawling position, and the participant was instructed to lift their knees off the ground and maintain that position.

    December 2022-September 2023

Secondary Outcomes (4)

  • Finger grip strength

    December 2022-September 2023

  • Hand function

    December 2022-September 2023

  • Fatigue severity

    December 2022-September 2023

  • Physical activity level

    December 2022-September 2023

Study Arms (2)

RA group

Core endurance, finger grip strength, hand function, fatigue, physical activity level, and disease activity were evaluated in patients diagnosed with RA.

Healthy controls

Core endurance, finger grip strength, hand function, fatigue, and physical activity level were evaluated in healthy control

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients RA diagnosis and health Controls

You may qualify if:

  • Diagnosed with RA according to ACR/EULAR criteria
  • Between 18-65 years of age
  • Willing to participate in the study

You may not qualify if:

  • Having any chronic disease other than RA
  • Having another musculoskeletal disease
  • Having adaptation problems and psychiatric illnesses that would impair participation in the study
  • Having hearing loss that would impair communication
  • Having severe vision loss
  • Having another rheumatic disease other than RA
  • Having any uncontrolled cardiopulmonary disease
  • Having a serious deformity or severe pain in the extremities or trunk that would prevent taking a crawling position (7 or higher on a 10-point numerical pain scale) (being present)
  • Hand deformity or pain severe enough to prevent finger grip strength measurements
  • History of any serious trauma or injury within the last 6 months
  • Changes in medication used for RA within the last 3 months
  • Receiving physiotherapy or other treatment other than medication
  • History of musculoskeletal surgery (trunk, extremities)
  • Being pregnant or breastfeeding
  • Being between 18-65 years of age
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sivas Cumhuriyet University

Sivas, 58140, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Arthritis, RheumatoidFatigue

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 9, 2026

First Posted

January 22, 2026

Study Start

December 8, 2022

Primary Completion

September 9, 2023

Study Completion

August 28, 2024

Last Updated

January 22, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations